TransCode Therapeutics advances Phase 1a trial of TTX-MC138 for metastatic cancer with early signs of stability and consistent PK/PD data.

-e, --encoder <string> Select video encoder: x264 x264_10bit nvenc_h264 x265 x265_10bit x265_12bit nvenc_h265 nvenc_h265_10bit mpeg4 mpeg2 VP8 VP9 HandBrake has exited.

In this interview with Streaming Media contributing editor Jan Ozer, Narayanan 'Raj' Rajan, CEO of Media Excel, reflects on his first year at the helm of one of the most established names in the ...

--TransCode Therapeutics, Inc.,, the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the closing of its previously announced sale of ...

TransCode Therapeutics (NASDAQ:RNAZ) announces to raise $10M through the purchase and sale of 10.25M shares of its common stock and warrants. Read more details here.

A current problem of transrating for HEVC is the high computational complexity associated with the encoder part of such a cascaded pixel domain transcoder. This paper focuses on deriving an optimal ...

No significant safety or dose limiting toxicities reported PK data from Cohorts 1 and 2 consistent with preclinical and Phase 0 trial results BOSTON, Feb. 6, 2025 /PRNewswire/ -- TransCode ...

Media transcoding is coming to the Microsoft PowerToys Advanced Paste tool (transcode audio and video from a copy/paste context menu) ...

TransCode Therapeutics Inc. (NASDAQ: RNAZ) shares are moving higher Friday after the company announced that the first patient in Cohort 3 of its Phase 1 clinical trial has been dosed with its lead ...

(RTTNews) - TransCode Therapeutics, Inc. (RNAZ), a company focused on cancer treatment using RNA therapeutics, said on Monday that its Board has approved a 1-for-33 reverse stock split.